CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 1.27M | 1.35M | +72.8K (+5.7%) |
| Value | $3.04M | $2.64M | −$403.0K (−13.2%) |
New holders (7)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 41,586 | $82.0K | 0.00% |
| Commonwealth Equity Services, LLC | 20,000 | $39.0K | 0.00% |
| State Street Corp | 17,988 | $35.0K | 0.00% |
| Two Sigma Securities, LLC | 11,061 | $22.0K | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 10,250 | $20.0K | 0.00% |
| Bank of America Corp | 2,000 | $4.00K | 0.00% |
| Sterling Financial Planning, Inc. | 600 | $1.00K | 0.00% |
Sold out (6)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citadel Advisors LLC | 92,404 | $221.0K |
| Essex Investment Management Co LLC | 59,565 | $142.0K |
| Bank of New York Mellon Corp | 43,659 | $104.0K |
| Jane Street Group, LLC | 13,747 | $33.0K |
| Goldman Sachs Group Inc | 11,566 | $28.0K |
| Sowell Financial Services LLC | 100 | $0 |